Hyperfine’s Swoop® Brain Imaging System Enhances Image Quality with AI Algorithms

Hyperfine, Inc., a pioneering medical device company, has announced the FDA clearance of updated software for its Swoop® ultra-low-field brain imaging system. This latest software release integrates advanced artificial intelligence (AI) algorithms into all sequences of the Swoop® system, including the diffusion-weighted imaging (DWI) sequence.

The incorporation of AI denoising capabilities into the DWI sequence enhances image quality by reducing noise, resulting in crisper and more accurate images. This improvement is expected to assist healthcare professionals in diagnosing, treating, and monitoring patients undergoing brain imaging, particularly in time-sensitive situations.

Tom Teisseyre, the Chief Operating Officer of Hyperfine, Inc., expressed his belief in making brain imaging more accessible, clinically relevant, and actionable. He emphasized the significant progress made across all sequences and the critical role that these imaging improvements will play in enhancing image quality for healthcare professionals in time-sensitive environments.

Maria Sainz, the President and CEO of Hyperfine, Inc., highlighted the company’s commitment to innovation and continuous improvement. With this eighth FDA software clearance in just three years, Hyperfine, Inc. demonstrates its dedication to reshaping patient care, empowering clinicians, and advancing brain imaging technology.

Hyperfine, Inc. plans to roll out the updated Swoop® system software in the coming months, further expanding the reach of their portable magnetic resonance brain imaging system. The Swoop® system has already received FDA clearance and approvals in several countries, including Canada, Australia, and the United Kingdom.

Hyperfine, Inc., founded by Dr. Jonathan Rothberg, aims to revolutionize patient care globally through accessible and clinically relevant diagnostic imaging solutions. The portable and ultra-low-field Swoop® system brings brain imaging to the patient’s bedside, eliminating the need for costly and stationary conventional MRI technology.

With the integration of AI algorithms into the Swoop® system, Hyperfine, Inc. continues to push the boundaries of brain imaging technology, providing healthcare professionals with advanced tools to improve patient outcomes.

For more information about the Swoop® Portable MR Imaging® System, please visit hyperfine.io.